News for Industry
Endonovo to Develop Cell Free Regenerative Products (MarketWatch)
(Los Angeles, CA) Endonovo therapeutics Inc. announced that they have developed technologies that will enable the manufacturing of regenerative products that will not require stem cells.
Aastrom Announces Appointments of Dr. Ross Tubo as Chief Scientific Officer and Dr. David Recker as Chief Medical Officer (Aaastrom)
(Ann Arbor, MI) Aastrom BioSciences Inc. announced the appointment of Dr. Ross Tubo as chief scientific Ofc. and Dr. David Recker as chief medical officer.
Mesoblast Announces Phase 2 Clinical Results For Lower Back Pain (Mesoblast)
(New York, NY) Mesoblast Ltd announced positive results for their year-long phase 2 clinical trial of mesenchymal precursor cells for the treatment of patients with chronic lower back pain.